Highlights Willow Biosciences Inc. OTC Markets

Equities

CANSF

CA97111B4047

Market Closed - OTC Markets Other stock markets 07:43:26 22/05/2024 pm IST			5-day change	1st Jan Change
0.0648 ^USD	-3.60%		-3.57%	-7.30%

13/05	Willow Biosciences Brief: Reiterating its Expectations of at least doubling its full year 2024 revenues, As Reports Q1 Results	MT
13/05	Willow Biosciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Willow Biosciences Brief: Reiterating its Expectations of at least doubling its full year 2024 revenues, As Reports Q1 Results	13/05	MT
Willow Biosciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	13/05	CI
Willow Biosciences Narrows 2023 Loss YOY	01/04	MT
Willow Biosciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	30/03	CI
Willow Biosciences Announces Second Strategic Investment From Kalsec	01/03	MT
Willow Biosciences Enters Partnership With Global Ingredient Manufacturer	31/01	MT
Willow Biosciences Inc. Announces Collaboration with Global Active Pharmaceutical Ingredient Manufacturer to Develop A More Sustainable, Cost-Effective Manufacturing Process for A Large Volume Global Market	31/01	CI
Willow Biosciences Announces Collaboration with Active Pharmaceutical Ingredient Manufacturer to Manufacture More Sustainable, Cost-Effective Manufacturing Route for Their Largest Product Sold Globally	31/01	CI
Willow Biosciences Announces Collaboration With Enterin	16/01	MT
Willow Biosciences Inc. Announces Collaboration with Enterin, Inc. to Develop Sustainable Interimates and Active Pharmaceutical Ingredients	16/01	CI
Willow Biosciences Highlights Growth Plans for 2024, Provides 2023 Highlights	10/01	MT
Willow Biosciences Brief: Says Plans For "Significant" Growth In 2024	10/01	MT
Willow Biosciences and Nasdaq-listed Biopharma Co Advancing Development Program	07/12	MT
Willow Biosciences Brief: Willow and a Nasdaq-listed biopharma company Advancing Development Program	07/12	MT
Willow Biosciences Reports Q3 Results, Provides Update	15/11	MT
Willow Biosciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15/11	CI
Aurora Cannabis Announcing Settlement of Patent Litigation	24/23/24	MT
Willow Biosciences and Suanfarma Detail Collaboration	03/23/03	MT
Willow Biosciences Inc. and Suanfarma Announce Collaboration on Development of Large Volume Anti-Infective API Through Precision Fermentation	03/23/03	CI
Willow Biosciences Announced Completion of R&D Program on Cost Effective, Sustainably Produced UDCA	06/23/06	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Willow Biosciences Inc. OTC Markets

Equities

CANSF

CA97111B4047

Highlights

Filters